Researchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 million Americans.
Georgia Tech engineers and Emory University clinicians have successfully engrafted insulin-producing cells into a diabetic mouse model, reversing diabetic symptoms in the animal in as little as 10 days.
The research team engineered a biomaterial to protect the cluster of insulin-producing cells – donor pancreatic islets – during injection. The material also contains proteins to foster blood vessel formation that allow the cells to successfully graft, survive and function within the body.
“It’s very promising,” said Andrés Garcia, Georgia Tech professor of mechanical engineering. “There is a lot of excitement because not only can we get the islets to survive and function, but we can also cure diabetes with fewer islets than are normally needed.”
The research article – a partnership with Emory’s Dr. Robert Taylor and Dr. Peter Thule that was funded in part by theJDRF, the leading global organization funding Type 1 diabetes research – will be published in the June issue of the journal Biomaterials.
Organizations such as JDRF are dedicated to finding a cure for Type 1 diabetes, a chronic disease that occurs when the pancreas produces little or no insulin, a hormone that allows the transport of sugar and other nutrients into tissues where they are converted to energy needed for daily life.
Pancreatic islet transplantation re-emerged as a promising therapy in the late 1990s. Patients with diabetes typically find it difficult to comply with multiple daily insulin injections, which only partially improve long-term outcomes. Successful islet transplantation would remove the need for patients to administer insulin. While islet transplantation trials have had some success, and control of glucose levels is often improved, diabetic symptoms have returned in most patients and they have had to revert to using some insulin.
Unsuccessful transplants can be attributed to several factors, researchers say. The current technique of injecting islets directly into the blood vessels in the liver causes approximately half of the cells to die due to exposure to blood clotting reactions. Also, the islets – metabolically active cells that require significant blood flow – have problems hooking up to blood vessels once in the body and die off over time.
Georgia Tech and Emory researchers engineered a hydrogel, a material compatible with biological tissues that is a promising therapeutic delivery vehicle. This water-swollen, cross-linked polymer surrounds the insulin-producing cells and protects them during injection. The hydrogel containing the islets was delivered to a new injection site on the outside of the small intestine, thus avoiding direct injection into the blood stream.
Once in the body, the hydrogel degrades in a controlled fashion to release a growth factor protein that promotes blood vessel formation and connection of the transplanted islets to these new vessels. In the study, the blood vessels effectively grew into the biomaterial and successfully connected to the insulin-producing cells.
Four weeks after the transplantation, diabetic mice treated with the hydrogel had normal glucose levels, and the delivered islets were alive and vascularized to the same extent as islets in a healthy mouse pancreas. The technique also required fewer islets than previous transplantation attempts, which may allow doctors to treat more patients with limited donor samples. Currently, donor cells from two to three cadavers are needed for one patient.
While the new biomaterial and injection technique is promising, the study used genetically identical mice and therefore did not address immune rejection issues common to human applications. The research team has funding from JDRF to study whether an immune barrier they created will allow the cells to be accepted in genetically different mice models. If successful, the trials could move to larger animals.
“We broke up our strategy into two steps,” said Garcia, a member of Georgia Tech’s Petit Institute for Bioengineering and Bioscience. “We have shown that when delivered in the material we engineered, the islets will survive and graft. Now we must address immune acceptance issues.”
The Latest Bing News on:
Diabetes mellitus type 1
- Biocon becomes the first generics company to get a diabetes drug approval in the UKon March 27, 2024 at 7:31 pm
Biocon Ltd. has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) U.K., for its complex formulation Liraglutide, which was filed through its European partner, ...
- Clinical and Immunological Features of Celiac Disease in Patients With Type 1 Diabetes Mellituson March 25, 2024 at 5:00 pm
Expert Rev Gastroenterol Hepatol. 2011;5(4):479-487. © 2011 Expert Reviews Ltd. Cite this: Clinical and Immunological Features of Celiac Disease in Patients With ...
- Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellituson March 20, 2024 at 5:00 pm
Type 1 diabetes mellitus is a chronic autoimmune disease caused by the pathogenic action of T lymphocytes on insulin-producing beta cells. Previous clinical studies have shown that continuous ...
- Diabetes Mellituson March 3, 2024 at 4:00 pm
Diabetes mellitus and sarcopenia pose a substantial ... and type 2 diabetes may be controlled with medications. Both type 1 and 2 are chronic conditions that usually cannot be cured.
- Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellituson February 28, 2024 at 3:59 pm
Type 1 diabetes mellitus is a chronic autoimmune disease caused by the pathogenic action of T lymphocytes on insulin-producing beta cells. Previous clinical studies have shown that continuous ...
- Type 1 diabetes articles from across Nature Portfolioon February 25, 2024 at 3:59 pm
Type 1 diabetes (also known as diabetes mellitus) is an autoimmune disease in which immune cells attack and destroy the insulin-producing cells of the pancreas. The loss of insulin leads to the ...
- New insulin mixture could make life easier for patients with type 1 diabeteson January 4, 2024 at 1:37 pm
The latest figures from the World Health Organization reveal that around 9 million of these had type 1 diabetes mellitus in 2017. Currently, approximately 26,000 Norwegians live with this ...
- Understanding Type 1 Diabetes Mellitus: A comprehensive guide for parentson November 14, 2023 at 6:41 am
Diabetes in children known as Type 1 Diabetes Mellitus, predominantly affects children and young adults aged between 4 and 14 years. It's a chronic condition that can be challenging to manage.
- Immunomodulation with microbial vaccines to prevent type 1 diabetes mellituson October 7, 2023 at 2:24 pm
In addition, a search of references cited in published reviews on the topic of immunotherapy for type 1 diabetes mellitus was performed, with a focus on articles published between January 1999 and ...
- Diabetes Mellitus Type 1 Newson August 9, 2022 at 5:00 pm
Increase in New-Onset Type 1 Diabetes in Kids During Pandemic The early days of the COVID-19 pandemic saw an increase in new-onset pediatric diabetes and DKA, while children with pre-existing ...
The Latest Google Headlines on:
Diabetes mellitus type 1
[google_news title=”” keyword=”Diabetes mellitus type 1″ num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Cure for type 1 diabetes
- Breakthrough Type 1 Diabetes drug now offered at OU Healthon March 26, 2024 at 5:31 pm
A new treatment targeting the root cause of Type 1 diabetes is now available at OU Health, and for pediatric patients at high risk, this new medication ...
- New treatment that could delay type 1 diabetes now offered at OU Healthon March 26, 2024 at 3:29 pm
OU Health recently finished the first 14 day infusion shown to delay the onset of type 1 diabetes by about two years.
- Type 1 diabetes researchers from across Canada sign letter of support for diabetes research to be included in the upcoming federal budgeton March 25, 2024 at 7:17 am
TORONTO, March 25, 2024 (GLOBE NEWSWIRE) -- Top researchers in the field of type 1 diabetes (T1D) signed an open letter in support of renewed funding for the JDRF-CIHR Partnership to Defeat diabetes ...
- Otelixizumab in the Treatment of Type 1 Diabetes Mellituson March 22, 2024 at 5:00 pm
in newly diagnosed Type 1 subjects, but in particular the placebo-controlled BDR-study using otelixizumab, uncovered important dose-dependent side-effects as described: flu-like symptoms (probably ...
- Cure for type-1 diabetes closer to reality through advances in genetic engineeringon March 22, 2024 at 9:07 am
But type-1 diabetes is a very different condition, where insulin-producing “beta” cells in the pancreas are destroyed by the body’s own immune system.
- Cure for type-1 diabetes closer to reality through advances in genetic engineeringon March 22, 2024 at 9:07 am
Studies with monkeys show that injecting high-insulin-producing forms of these cells into the animals can “cure” type-1 diabetes for about six months. Human trials are underway. But a better ...
- 'First Big Step Towards a Cure': Revolutionary Type 1 Diabetes Drug at OU Healthon March 19, 2024 at 3:52 pm
A breakthrough in Type 1 diabetes research has made its way to the metro: a drug that can actually slow down the progression of the disease.
- 'First Big Step Towards a Cure': Revolutionary Type 1 Diabetes Drug at OU Healthon March 19, 2024 at 10:14 am
"We think that we'll be able to delay this young ladies’ treatment for years and years, which is exciting," he said. Dr. Sparling added that the future of Type 1 diabetes research is bright.
- Team reports progress in developing specific immunotherapies for type 1 diabeteson March 18, 2024 at 12:56 pm
Researchers from Germans Trias i Pujol Research Institute (IGTP) and Ahead Therapeutics SL have been exploring a treatment based on liposome-type nanoparticles to address the autoimmunity of type 1 ...
- Dr. Roach: Lab results signify prompt treatment for Type 1 diabeteson February 26, 2024 at 9:01 pm
Type 1 diabetes typically presents itself more slowly in adults, so it’s likely you had the antibodies for a long time before you were diagnosed. Treatment with insulin is effective at ...
The Latest Google Headlines on:
Cure for type 1 diabetes
[google_news title=”” keyword=”cure for type 1 diabetes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]